Fast Market Research

Market Report, "Global Rheumatoid Arthritis Drugs Market 2014-2018", Published

New Pharmaceuticals market report from TechNavio: "Global Rheumatoid Arthritis Drugs Market 2014-2018"

 

Boston, MA -- (ReleaseWire) -- 07/24/2014 -- RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation of the tissues that surround the joints and in other organs. The symptoms of RA begin slowly, usually just mild pain around the joints coupled with stiffness and fatigue, and in the later stages it causes inflammation of the joints. It can occur at any age, even in children, which is called juvenile arthritis. The disease is three times more common in women than in men. Genetic and environmental elements are known to contribute in the development of RA.

View Full Report Details and Table of Contents

TechNavio's analysts forecast the Global Rheumatoid Arthritis Drugs market will grow at a CAGR of 4.09 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Rheumatoid Arthritis Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of RA that are available in the market. The Global Rheumatoid Arthritis Drugs market can be divided into two segments: Symptomatic and DMARDs.

TechNavio's report, the Global Rheumatoid Arthritis Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Rheumatoid Arthritis Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

- Americas
- EMEA
- APAC

Key Vendors

- AbbVie Inc.
- Amgen Inc.
- Bristol-Myers Squibb Co.
- F. Hoffmann-La Roche Ltd.
- Janssen Pharmaceuticals Inc.
- Pfizer Inc.

Other Prominent Vendors

- AB Science SA
- Astellas Pharma Inc.
- AstraZeneca plc
- Biogen Idec Inc.
- Boehringer Ingelheim GmbH
- Celgene Corp.
- Daiichi Sankyo Co. Ltd.
- Eli Lilly & Co.
- GE Healthcare Co.
- Genmab A/S
- GSK plc
- Incyte Corp.
- Merck & Co. Inc.
- Mitsubishi Tanabe Pharma Corp.
- Novartis AG
- Novo Nordisk A/S
- Rigel Pharmaceuticals Inc.
- Sanofi
- Takeda Pharmaceutical Co. Ltd.
- UCB SA
- Vertex Pharmaceuticals Inc.

Key Market Driver

- Increasing Aging Population
- For a full, detailed list, view our report.

Key Market Challenge

- High Cost of RA Treatment
- For a full, detailed list, view our report.

Key Market Trend

- Increase in R&D Activities
- For a full, detailed list, view our report.

Key Questions Answered in this Report

- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Companies Mentioned in this Report: AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Janssen Pharmaceuticals Inc., Pfizer Inc., AB Science SA, Astellas Pharma Inc., AstraZeneca plc, Biogen Idec Inc., Boehringer Ingelheim GmbH, Celgene Corp., Daiichi Sankyo Co. Ltd., Eli Lilly & Co., GE Healthcare Co., Genmab A/S, GSK plc, Incyte Corp., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corp., Novartis AG, Novo Nordisk A/S, Rigel Pharmaceuticals Inc., Sanofi, Takeda Pharmaceutical Co. Ltd., UCB SA, Vertex Pharmaceuticals Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Rheumatoid Arthritis - Pipeline Review, H1 2014
- Frontier Pharma: Rheumatoid Arthritis - Identifying and Commercializing First-in-Class Innovation
- Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline
- Psoriatic Arthritis Global Clinical Trials Review, H2, 2013
- Rheumatoid Arthritis - Pipeline Review, H2 2013
- Arthritis Global Clinical Trials Review, H2, 2013
- Advanced in the Rheumatoid Arthritis Market
- Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2013
- Biosimilars Market - Global Forecast to 2018
- Rheumatoid Arthritis Partnering 2009-2014